Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Guardant Health, Inc. stock logo
GH
Guardant Health
$42.89
+5.5%
$42.83
$15.81
$50.89
$5.02B1.52.14 million shs1.76 million shs
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$33.10
+5.0%
$38.49
$11.20
$72.98
$7.35B1.3713.49 million shs17.05 million shs
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$32.66
+1.3%
$30.81
$21.39
$34.85
$5.33B1.331.63 million shs2.19 million shs
Progyny, Inc. stock logo
PGNY
Progyny
$20.36
+2.6%
$21.58
$13.39
$38.98
$1.74B1.411.59 million shs1.61 million shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Guardant Health, Inc. stock logo
GH
Guardant Health
+5.54%+9.08%-5.49%+23.39%+125.74%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
+5.21%-8.08%-28.70%+10.27%+118.94%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
+1.30%-3.97%+2.51%+39.04%+0.77%
Progyny, Inc. stock logo
PGNY
Progyny
+2.62%-2.12%-7.54%+39.36%-44.51%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Guardant Health, Inc. stock logo
GH
Guardant Health
4.2722 of 5 stars
3.52.00.04.43.32.50.6
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
3.3612 of 5 stars
3.12.00.00.03.13.31.9
Option Care Health, Inc. stock logo
OPCH
Option Care Health
4.2369 of 5 stars
2.45.00.04.23.72.50.6
Progyny, Inc. stock logo
PGNY
Progyny
2.3172 of 5 stars
2.22.00.00.02.74.21.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Guardant Health, Inc. stock logo
GH
Guardant Health
3.00
Buy$48.4012.85% Upside
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.27
Hold$37.2312.47% Upside
Option Care Health, Inc. stock logo
OPCH
Option Care Health
2.75
Moderate Buy$33.001.04% Upside
Progyny, Inc. stock logo
PGNY
Progyny
2.31
Hold$24.8221.90% Upside

Current Analyst Ratings Breakdown

Latest PGNY, HIMS, OPCH, and GH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/6/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$42.00 ➝ $52.00
3/6/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderperform ➝ Underperform$21.00 ➝ $21.00
3/6/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell ➝ Sell$27.00 ➝ $27.00
3/6/2025
Option Care Health, Inc. stock logo
OPCH
Option Care Health
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$40.00 ➝ $41.00
2/28/2025
Progyny, Inc. stock logo
PGNY
Progyny
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$17.00 ➝ $23.00
2/27/2025
Option Care Health, Inc. stock logo
OPCH
Option Care Health
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$33.00 ➝ $38.00
2/26/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$34.00 ➝ $50.00
2/26/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$24.00 ➝ $39.00
2/25/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform ➝ Market Perform$24.00 ➝ $40.00
2/25/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$24.00 ➝ $35.00
2/25/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSell ➝ Sell$25.00 ➝ $27.00
(Data available from 3/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Guardant Health, Inc. stock logo
GH
Guardant Health
$739.02M7.16N/AN/A$1.34 per share32.01
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$1.48B4.98N/AN/A$1.61 per share20.56
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$5.00B1.08$1.90 per share17.19$8.03 per share4.07
Progyny, Inc. stock logo
PGNY
Progyny
$1.17B1.49$0.57 per share35.58$5.77 per share3.53
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Guardant Health, Inc. stock logo
GH
Guardant Health
-$479.45M-$3.56N/AN/AN/A-59.05%-19,157.20%-25.96%5/8/2025 (Estimated)
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-$23.55M$0.5475.2463.66N/A8.19%10.97%8.29%5/5/2025 (Estimated)
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$267.09M$1.2227.4525.922.304.37%15.30%6.57%4/22/2025 (Estimated)
Progyny, Inc. stock logo
PGNY
Progyny
$62.04M$0.5735.1031.322.395.03%11.36%7.87%5/8/2025 (Estimated)

Latest PGNY, HIMS, OPCH, and GH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/24/2025Q4 2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.09$0.11+$0.02$0.11$494.56 million$481.14 million
2/20/2025Q4 2024
Guardant Health, Inc. stock logo
GH
Guardant Health
-$0.75-$0.90-$0.15-$0.90$192.50 million$201.81 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Guardant Health, Inc. stock logo
GH
Guardant Health
N/AN/AN/AN/AN/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
Option Care Health, Inc. stock logo
OPCH
Option Care Health
N/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Guardant Health, Inc. stock logo
GH
Guardant Health
N/A
6.22
5.85
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/A
2.14
1.82
Option Care Health, Inc. stock logo
OPCH
Option Care Health
0.77
1.73
1.32
Progyny, Inc. stock logo
PGNY
Progyny
N/A
2.62
2.62

Institutional Ownership

CompanyInstitutional Ownership
Guardant Health, Inc. stock logo
GH
Guardant Health
92.60%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
98.05%
Progyny, Inc. stock logo
PGNY
Progyny
94.93%

Insider Ownership

CompanyInsider Ownership
Guardant Health, Inc. stock logo
GH
Guardant Health
5.50%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
17.71%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
0.64%
Progyny, Inc. stock logo
PGNY
Progyny
12.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Guardant Health, Inc. stock logo
GH
Guardant Health
1,779123.42 million116.76 millionNot Optionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
1,046222.17 million179.79 millionOptionable
Option Care Health, Inc. stock logo
OPCH
Option Care Health
5,600165.32 million169.09 millionOptionable
Progyny, Inc. stock logo
PGNY
Progyny
31085.41 million74.68 millionOptionable

Recent News About These Companies

Progyny launches Parent and Child Well-being Offering
Truist Financial Sticks to Its Hold Rating for Progyny (PGNY)
Progyny price target raised to $34 from $30 at BofA
Progyny price target raised to $23 from $17 at Canaccord
Progyny projects slower revenue growth after losing Amazon

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Guardant Health stock logo

Guardant Health NASDAQ:GH

$42.89 +2.25 (+5.54%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$42.74 -0.16 (-0.36%)
As of 03/14/2025 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Hims & Hers Health stock logo

Hims & Hers Health NYSE:HIMS

$33.10 +1.56 (+4.96%)
Closing price 03/14/2025 03:59 PM Eastern
Extended Trading
$33.28 +0.17 (+0.52%)
As of 03/14/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Option Care Health stock logo

Option Care Health NASDAQ:OPCH

$32.66 +0.42 (+1.30%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$32.43 -0.23 (-0.70%)
As of 03/14/2025 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Progyny stock logo

Progyny NASDAQ:PGNY

$20.36 +0.52 (+2.62%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$20.36 0.00 (0.00%)
As of 03/14/2025 06:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.